With that becoming said, with no human trials there's no way to actually evaluate the amount of YK11 can inhibit Myostatin in people (if in any respect), and when there is a dosage which could equate to exactly the same volume of Myostatin inhibition that a genetic anomaly having a gene mutation has.Figure two: body weight with the prostate seminal